Rankings
▼
Calendar
BVS FY 2014 Earnings — Bioventus Inc. Revenue & Financial Results | Market Cap Arena
BVS
Bioventus Inc.
$581M
FY 2014 Earnings
Healthcare
Medical - Devices
Income Statement
Revenue
$243M
+4.5% YoY
Gross Profit
$168M
69.3% margin
Operating Income
$20,000
0.0% margin
Net Income
-$13M
-5.3% margin
EPS (Diluted)
$-0.30
Cash Flow
Operating Cash Flow
$15M
Free Cash Flow
-$6M
Stock-Based Comp.
$0
Balance Sheet
Total Assets
$430M
Total Liabilities
$253M
Stockholders' Equity
$177M
Cash & Equivalents
$16M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$243M
$232M
+4.5%
Gross Profit
$168M
$161M
+4.5%
Operating Income
$20,000
-$8M
+100.2%
Net Income
-$13M
-$22M
+42.3%
← FY 2013
All Quarters
Q1 2015 →